Celsion (CLSN) Sinks on Negative Article
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Negative Celsion (CLSN) Blogger at it Again
June 13, 2013 11:19 AM EDTSeekingAlpha contributor Alpha Exposure is not giving up on Celsion Corporation (NASDAQ: CLSN). The contributor is out with it second negative article in the past few days even after the company was out defending itself Wednesday calling the first blog post "misleading."
... More
Celsion (CLSN) Said Blog Post 'Misleading'
June 12, 2013 3:42 PM EDTCelsion Corporation (NASDAQ: CLSN) responds to a negative SeekingAlpha blog post:
"Statements made in Alpha Exposure's blog entry are misleading and require clarification.
As is common in the biotechnology and pharmaceutical industry, Celsion has conducted a comprehensive post hoc analysis of the data from its Phase III HEAT Study of ThermoDox® in hepatocellular carcinoma (HCC) with its key principal investigators, data experts and liver cancer experts. This analysis followed the announcement on January 31, 2013, that ThermoDox® in combination with radiofrequency ablation (RFA) did not meet the Study's primary endpoint. Emerging... More
Celsion (CLNS) CEO Buys 10K Shares In Light of Negative Article
June 12, 2013 10:30 AM EDTAmid a negative SeekingAlpha article, Celsion Corporation (NASDAQ: CLSN) CEO Michael Tardungo disclosed the purchase of 10,000 shares made today at $1.3457.... More
